BUY Jubilant Ingrevia Limited — Anand Rathi
byAnand RathiHorizon: NA (inferred 1 year)28 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth
NewsCnbc-Tv18·27 Oct · yesterday
3 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·24 Sept · 1mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·28 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Jubilant Ingrevia
- BUY — Rachna Vaidya27 Oct 2026 · ~2 weeks · target ₹660 · SL hit
- BUY — Siddharth Rai Mangala28 Sept 2026 · ~2 weeks · target ₹720 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities25 Sept 2026 · ~1 year · target ₹775 · SL hit
- BUY — Axis Securities24 Sept 2026 · ~1 year · target ₹705 · Active
- BUY — Kotak Securities23 Sept 2026 · ~1 year · target ₹1,010 · Active
More from Anand Rathi
- BUY JK Cement27 Oct 2026 · ~1 year · target ₹6,078 · Active
- BUY Atul27 Oct 2026 · ~1 year · target ₹7,900 · Active
- BUY Havells India25 Oct 2026 · ~1 year · target ₹1,285 · Active
- BUY DCB Bank25 Oct 2026 · ~1 year · target ₹312 · Active
- BUY SHREE CEMENT25 Oct 2026 · ~1 year · target ₹28,021 · Active

